From the *Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
†Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
‡School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia
§Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
¶Department of Intensive Care, North Estonia Medical Centre, Tallinn, Estonia
∥Department of Pathophysiology and Transplantation, UniversitĂ degli Studi di Milano, Milan, Italy.
Submitted for consideration August 2022; accepted for publication in revised form January 2023.
Disclosure: The authors have no conflicts of interest to report.
S.H. received a PhD scholarship from The Prince Charles Hospital Foundation (Australia) for his PhD. D.K. received a PhD scholarship from the Griffith University (Australia) for his PhD. J.Y.S. received a research fellowship from the Advance Queensland Industry Research Fellowships program (Australia).
D.K., S.H., J.Y.S., J.P., V.T.D., L.G., and J.F.F. conceptualized and designed the study. D.H., J.P., and S.H. conducted the literature search. D.H., S.H., and J.P. conducted screening processes for articles. D.K., S.H., and L.G. performed data acquisition, conceptualization, and processing. D.K., S.H., and L.G. drafted the first draft of the manuscript. All authors assisted in drafting the final version and provided critical revision of the article.
D.K. and S.H. contributed equally as co-first authors.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML and PDF versions of this article on the journal’s Web site (www.asaiojournal.com).
Correspondence: Dhayananth Kanagarajan, Critical Care Research Group, The Prince Charles Hospital, Chermside, Brisbane, QLD, Australia. Email: [email protected]; Twitter: @silverheinsar.
